Target intelligence / Profile preview

CATIP antisense RNA 2 (CATIP-AS2)

Target
CATIP-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

CATIP antisense RNA 2 (CATIP-AS2) is a long non-coding antisense RNA (lncRNA) transcribed from the genome and classified as an antisense RNA molecule[1][6]. Antisense RNAs, including lncRNAs, are not translated into proteins but can bind to and regulate the stability, translation, or chromatin context of target messenger RNAs or nearby genes[4][7]. CATIP-AS2 is associated with the lncRNA class and has been linked to the rare human condition spermatogenic failure 54 in genetic studies, but there is no evidence that it functions as a classical therapeutic target such as a receptor, enzyme, transporter, or signaling protein. No disease-modifying drugs, biomarker evidence, or clinical relevance as a drug target have been described. The gene is catalogued in genomic resources but lacks functional or mechanistic characterization regarding direct therapeutic utility[1][6].

Other names
CATIP-AS2CATIP antisense RNA 2
02

Biological functions

Regulation of gene expression (via antisense mechanism)Possible involvement in transcriptional and post-transcriptional gene silencing
03

Disease associations

Spermatogenic failure 54 (association—based on correlation, not on a direct mechanistic role)

Beyond the preview

Go deeper on CATIP antisense RNA 2 (CATIP-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CATIP antisense RNA 2 (CATIP-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call